Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-039558

Options or other derivatives

  • Chief Operating Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Williams Gregory C. Chief Operating Officer 2018-06-25 Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000 D
Loading xslF345X03/doc4.xml…